Related references
Note: Only part of the references are listed.Population-level distribution and putative immunogenicity of cancer neoepitopes
Mary A. Wood et al.
BMC CANCER (2018)
The Immune Revolution: A Case for Priming, Not Checkpoint
Robert H. Vonderheide
CANCER CELL (2018)
Effective cancer immunotherapy based on combination of TLR agonists with stimulation of phagocytosis
Veronika Caisova et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Eradication of spontaneous malignancy by local immunotherapy
Idit Sagiv-Barfi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Heating it up: Oncolytic viruses make tumors hot' and suitable for checkpoint blockade immunotherapies
Shashi Gujar et al.
ONCOIMMUNOLOGY (2018)
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
Saman Maleki Vareki
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Complement in cancer: untangling an intricate relationship
Edimara S. Reis et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Innate immune signaling and regulation in cancer immunotherapy
Leticia Corrales et al.
CELL RESEARCH (2017)
New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Joakim Crona et al.
ENDOCRINE REVIEWS (2017)
Excellent response to chemotherapy post immunotherapy
Ashish D. Dwary et al.
ONCOTARGET (2017)
Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior
David J. Pinato et al.
ONCOIMMUNOLOGY (2017)
Intratumoral immunotherapy: using the tumor as the remedy
A. Marabelle et al.
ANNALS OF ONCOLOGY (2017)
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
CANCER CELL (2017)
Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model
Veronika Caisova et al.
BMC CANCER (2016)
A journey through the lectin pathway of complementMBL and beyond
Peter Garred et al.
IMMUNOLOGICAL REVIEWS (2016)
The use of Zymosan A and bacteria anchored to tumor cells for effective cancer immunotherapy: B16-F10 murine melanoma model
Eva Waldmannova et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Phagocytosis: receptors, signal integration, and the cytoskeleton
Spencer A. Freeman et al.
IMMUNOLOGICAL REVIEWS (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
The Use of Anchored Agonists of Phagocytic Receptors for Cancer Immunotherapy: B16-F10 Murine Melanoma Model
Tereza Janotova et al.
PLOS ONE (2014)
Allogeneic tumor cell vaccines The promise and limitations in clinical trials
Sanjay Srivatsan et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
Agonistic CD40 Antibodies and Cancer Therapy
Robert H. Vonderheide et al.
CLINICAL CANCER RESEARCH (2013)
M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway
Chao-Ying Liu et al.
LABORATORY INVESTIGATION (2013)
Progenitor Cell Line (hPheo1) Derived from a Human Pheochromocytoma Tumor
Hans K. Ghayee et al.
PLOS ONE (2013)
Murine Models and Cell Lines for the Investigation of Pheochromocytoma: Applications for Future Therapies?
Esther Korpershoek et al.
ENDOCRINE PATHOLOGY (2012)
Toll-Like Receptor 7 Agonist Therapy with Imidazoquinoline Enhances Cancer Cell Death and Increases Lymphocytic Infiltration and Proinflammatory Cytokine Production in Established Tumors of a Renal Cell Carcinoma Mouse Model
Eric C. Kauffman et al.
JOURNAL OF ONCOLOGY (2012)
A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma: A Phase II Trial of Safety, Efficacy, and Immune Activation
Eric Lutz et al.
ANNALS OF SURGERY (2011)
Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth
Zhenyu Cai et al.
CANCER RESEARCH (2011)
Chromogranin A as potential target for immunotherapy of malignant pheochromocytoma
Claudia Papewalis et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Joshua D. Brody et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and Devices
Meghan G. Lubner et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer-Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells
Uciane K. Scarlett et al.
CANCER RESEARCH (2009)
Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature
Lucia Martiniova et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Raul Elgueta et al.
IMMUNOLOGICAL REVIEWS (2009)
Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice
Jing Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
TLR3:: Interferon induction by double-stranded RNA including poly(I:C)
Misako Matsumoto et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Polarized immune responses differentially regulate cancer development
Magnus Johansson et al.
IMMUNOLOGICAL REVIEWS (2008)
History of bacillus Calmette-Guerin and bladder cancer: An immunotherapy success story
Harry W. Herr et al.
JOURNAL OF UROLOGY (2008)
Lipoteichoic acid is important in innate immune responses to gram-positive bacteria
Ho Seong Seo et al.
INFECTION AND IMMUNITY (2008)
Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases
Renee Lengagne et al.
JOURNAL OF IMMUNOLOGY (2008)
Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases
Ping Yu et al.
JOURNAL OF IMMUNOLOGY (2007)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells
G Napolitani et al.
NATURE IMMUNOLOGY (2005)
Toll-like receptors in innate immunity
K Takeda et al.
INTERNATIONAL IMMUNOLOGY (2005)
The lectin-complement pathway - its role in innate immunity and evolution
T Fujita et al.
IMMUNOLOGICAL REVIEWS (2004)
Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN
CL Ahonen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses
JJ Wu et al.
ANTIVIRAL RESEARCH (2004)
TNF-α induces phosphorylation of p47phox in human neutrophils:: Partial phosphorylation of p47phox is a common event of priming of human neutrophils by TNF-α and granulocyte-macrophage colony-stimulating factor
C Dewas et al.
JOURNAL OF IMMUNOLOGY (2003)
Toll-like receptors and innate immunity
R Medzhitov
NATURE REVIEWS IMMUNOLOGY (2001)
Share Paper
